Matinas BioPharma Holdings, Inc.
MTNB
$0.59
-$0.05-7.84%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.10% | -49.65% | -54.41% | -14.62% | -47.05% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -96.24% | -81.25% | -24.84% | -73.09% | -60.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -49.22% | -51.85% | -52.45% | -26.65% | -48.37% |
|
|
|||||
| Total Current Assets | -49.22% | -51.85% | -52.45% | -26.65% | -48.37% |
| Net Property, Plant & Equipment | -68.78% | -64.70% | -64.08% | -57.47% | -56.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -21.36% | -21.36% | -23.53% | -23.53% |
| Total Assets | -42.98% | -52.88% | -53.11% | -38.63% | -49.65% |
|
|
|||||
| Total Accounts Payable | 231.58% | -77.08% | -29.83% | -40.38% | -81.52% |
| Total Accrued Expenses | -74.96% | -45.61% | -44.87% | 40.52% | 24.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.14% | 15.31% | 15.45% | 15.74% | 15.89% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -45.12% | -29.61% | -25.42% | 12.86% | 1.68% |
|
|
|||||
| Total Current Liabilities | -45.12% | -29.61% | -25.42% | 12.86% | 1.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -69.08% | -36.43% | -32.46% | -29.23% | -26.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -24.63% | -24.63% | 366.28% | -24.63% |
| Total Liabilities | -52.92% | -32.58% | -28.75% | 14.11% | -13.78% |
|
|
|||||
| Common Stock & APIC | 3.95% | 3.94% | 3.94% | 5.95% | 6.34% |
| Retained Earnings | -5.49% | -9.14% | -10.48% | -11.07% | -13.81% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -36.36% | -59.06% | -59.82% | -56.93% | -60.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.36% | -59.06% | -59.82% | -56.93% | -60.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.36% | -59.06% | -59.82% | -56.93% | -60.56% |
|
|
|||||